Azitra Inc (AZTR)
NYSE American · Manufacturing · Pharmaceutical preparations
AZTR price, last 12 months
Key stats
- Previous close
- $0.1176
- Open
- $0.1207
- Day range
- $0.0518 – $0.1213
- 52-week range
- $0.0518 – $2.13
- Volume
- 2.7M
- Avg volume (20 days)
- 856.3K
- Market cap
- $10.0M
Performance
Technicals and fundamentals
About Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE American
- Market cap
- $10.0M